Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), sold 2,938 shares at $4.37 ($13K) on 2021-06-21, disclosed to the SEC on 2021-06-23.
Scheduled sale ($13k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CLSD | SELL | 2022-01-20 | $18K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2020-06-03 | $28K | — | Filing → |